CHOCO-CABANA Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT04539145

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04539145
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Germany, New Zealand (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04539145. Randomized; single masking; primary purpose treatment. Start 2020-08-04 (actual); primary completion 2022-03-27 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CHOCO-CABANA Trial
Condition
Atherosclerosis
Intervention (Device)
Chocolate PTA Balloon
Intervention (Device)
conventional balloon angioplasty
Lead sponsor
Klinikum Rosenheim (class: other)
Collaborator
Medtronic (class: industry)
Collaborator
Herz-Zentrums Bad Krozingen (class: other)
Collaborator
University Hospital Tuebingen (class: other)
Collaborator
Klinikum Karlsbad-Langensteinbach (class: other)
Collaborator
Elblandklinikum Radebeul Interdisziplinäres Gefäßzentrum Radebeul / Riesa (class: not stated)
Collaborator
Universitäts-Frauenklinik Graz (class: other)
Collaborator
Hanusch-Krankenhaus Kardiovaskuläres Zentrum (class: not stated)
Collaborator
Auckland City Hospital (class: other government)
Collaborator
SCO:SSiS (class: not stated)
Collaborator
coreLab Black Forest GmbH (class: not stated)
Collaborator
Charite University, Berlin, Germany (class: other)

Record details

Record id
cardio:ct-nct04539145
Content hash
90720538ef73ffd65d3efe8c07a4164dba917722543b2575c96913526a43d383